+0.110 (+1.21%)
Range 9.200 - 9.230   (0.33%)
Open 9.206
Previous Close 9.120
Buy Price 9.220
Buy Volume 418
Sell Price 9.230
Sell Volume 215
Volume 3,150,136
Value -
Measurement Type Value
EPS (USD) -0.479
Trailing EPS (USD) -0.193
NAV (USD) 1.843
Cash In Hand (USD) 0.284
Dividend -
Dividend Yield (%) -
PE -
Trailing PE -
Price / NAV 4.949
Price / Cash In Hand 32.113
Issued & Paid-up Shares 45,462,300
Treasury Shares -
Market Cap (M) 414.616
Par Value (USD) n.a.
Beta - 75 Days 0.239
R-Squared - 75 Days(%) -
Beta - 500 Days 1.097
R-Squared - 500 Days(%) 11.67
ISIN Code -
Under CPF Investment Scheme (CPFIS) No
Index Components
Delayed prices. Updated at 03 Aug 2021 04:00.
Data powered by

Upcoming Events

* Stock event date based on US timezone.


Release Date 05 Aug 2021
View All Events


Kindred Biosciences, Inc. is a development-stage biopharmaceutical company. The Company focused on pets. In addition, it has seven other product candidates, including several biologics, in various stages of development. The Company�s product candidates are CereKin for the treatment of osteoarthritis pain and inflammation in dogs, AtoKin for the treatment of atopic dermatitis in dogs, and SentiKin for the treatment of post-operative pain in dogs. All of these product candidates, if approved, would be first-in-class drugs in the pet therapeutic market. The Company�s product pipeline consists of small molecules and biologics in various stages of development for a range of indications in dogs, cats and horses. Small molecules are generally chemical compounds administered orally and biologics are generally proteins and vaccines administered by injection.

Loading Chart...